menu
    • menu

    Company profile for EnteroBiotix

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our vision is to transform the standard of care for patients suffering from substantial unmet clinical needs through microbiome modulating therapeutics and in doing so, create a sustainable pharmaceutical company. It established proprietary MHRA licensed manufacturing capabilities and a supply chain model that enables us to leverage a pipeline of internal and partnered programmes around our lead asset, EBX-101. We operate sit...
    Our vision is to transform the standard of care for patients suffering from substantial unmet clinical needs through microbiome modulating therapeutics and in doing so, create a sustainable pharmaceutical company. It established proprietary MHRA licensed manufacturing capabilities and a supply chain model that enables us to leverage a pipeline of internal and partnered programmes around our lead asset, EBX-101. We operate sites in Aberdeen and Glasgow, Scotland.Our Board of Directors are all highly accomplished biopharmaceutical executives that each have a successful track record in delivering value building milestones for shareholders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnteroBiotixunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Unit 2.3 Western Campus Strathclyde Business Park Scotland ML4 3PU
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enterobiotix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enterobiotix/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/enterobiotix

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enterobiotix Reports Positive Phase 2 Results For EBX-102-02
    Enterobiotix Reports Positive Phase 2 Results For EBX-102-02

    08 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-08/enterobiotix-announces-positive-phase-2-triumph-results-supporting-ebx-102-02-as-a-potential-first-in-class-oral-full-spectrum-microbiome-therapy-fo-1

    PHARMIWEB
    08 Jan 2026
    Share Share
    EnteroBiotix Shows Positive Liver Cirrhosis Data at EASL 2025
    EnteroBiotix Shows Positive Liver Cirrhosis Data at EASL 2025

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080024/0/en/EnteroBiotix-Presents-Positive-Data-in-Liver-Cirrhosis-at-EASL-2025.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    EnteroBiotix Shares Positive IBS-C Data at Digestive Disease Week
    EnteroBiotix Shares Positive IBS-C Data at Digestive Disease Week

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3074896/0/en/EnteroBiotix-Presents-Positive-IBS-C-Data-at-Digestive-Disease-Week-2025.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    EnteroBiotix to Present Ph 1b Liver Cirrhosis Trial Results
    EnteroBiotix to Present Ph 1b Liver Cirrhosis Trial Results

    02 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/02/3073044/0/en/EnteroBiotix-to-Present-Results-from-Phase-1b-trial-in-Liver-Cirrhosis-at-EASL-Congress-2025.html

    GLOBENEWSWIRE
    02 May 2025
    Share Share
    EnteroBiotix to Present Phase 2a IBS-C Results at DDW 2025
    EnteroBiotix to Present Phase 2a IBS-C Results at DDW 2025

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069132/0/en/EnteroBiotix-Announces-Oral-Presentation-of-Phase-2a-IBS-C-Results-at-Digestive-Disease-Week-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    EnteroBiotix Reports Positive Phase 2a Results for IBS Treatment
    EnteroBiotix Reports Positive Phase 2a Results for IBS Treatment

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044218/0/en/EnteroBiotix-Announces-Positive-Topline-Phase-2a-Results-with-EBX-102-02-a-Potential-First-in-Class-Treatment-for-Irritable-Bowel-Syndrome-IBS.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search